Houston restaurateurs share business lessons learned

Restaurant Boot Camp

A panel of restaurateurs discussed business lessons learned at a panel event hosted by Briggs & Veselka. Eric Sandler/CultureMap

Storied Houston restaurateurs and business and media professionals gathered last week for Restaurant Boot Camp, an event that highlighted Houston's vibrant restaurant landscape. The corporate conference center of Briggs & Veselka was aptly decorated with checkerboard tablecloths and "menus" of the event agenda. Panelists addressed such diverse and timely topics as restaurant concepts and marketing, operations, fundraising and employee retention. Briggs & Veselka, one of the few accounting firms with a group dedicated to the restaurant and hospitality industry, sponsored the event, alongside partners ADP, Culturemap and NextSeed.

A panel discussion entitled "Lessons Learned" featured insights from some of Houston's top restaurateurs, including Tony Vallone (Tony's), Ben Berg (B&B Butcher), Lonnie Shiller (Shiller Del Grande Restaurant Group and Paul Miller (GR8 Plate Hospitality). Moderated by CultureMap and InnovationMap's parent company, Gow Media, CEO David Gow, the panel highlighted the rise of online marketing and social media. Berg pointed out that guests at his restaurant consistently take pictures of their food to post on social media, providing natural promotion of the restaurant. All cited how, in the past, they would have to wait weeks for a letter, but now get feedback from guests immediately by reading online reviews.

Vallone, whose iconic restaurant celebrated its fiftieth anniversary this month, cited the need to innovate.

"We must continue to evolve. We can't rest on our laurels," he says.

All businesses need to be well-funded. In a presentation called "Show Me the Money," Tae Mi Lee of NextSeed shares how restaurants can raise capital through crowdfunding. NextSeed provides the legal and fundraising infrastructure to raise either debt or equity in small increments from a large number of participants.

As a previous CultureMap article mentions, several Houston restaurants have raised funds through NextSeed, and two new Houston restaurant concepts currently have campaigns live on the site. Even in this discussion, marketing emerged as a key topic: the fundraising effort provides visibility for the restaurant, and investors inevitably become committed to its success, developing a potentially large and loyal following.

Another hot topic: finding, motivating and retaining good people. Thomas Nguyen, chief marketing officer and partner at Peli Peli, cited how his group invests more time up front in the hiring process.

"We try to ask deeper questions to learn more about whether the person will be a good fit."

Sam Herskovitz of ADP noted in his presentation, "Attracting and Retaining People," that good team leaders are those who engage and acknowledge all members of the team. There was universal acknowledgment that the quality of the team is a key driver to providing a consistently great experience for guests.

Another interesting discussion focused on new technologies. New tools such as point-of-sale and reporting technologies have been helpful to many, but several cited their concerns over food delivery apps such as DoorDash and Uber Eats. Though a great convenience to those who wish to eat at home, the consensus of the restaurateurs was negative. The issue: the restaurant loses some control over the dining experience.

Between serving delicious food with excellent service and using innovative marketing and technology strategies, Houston restaurateurs have a lot on their plates. Schiller summed it up best.

"Around the country, people talk about Houston food. Houston has no ocean or mountains," Schiller says. "We have to do something… we go out to eat."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.